Cancer News

Medindia's Press Release’ section provides the latest press release on Cancer from across the world for the global audience. This page links to 7078 Cancer press releases.

Ariceum Therapeutics Granted UK Authorisation to Conduct Phase I Clinical Study of its First-in-Class Iodine-123 Labelled PARP Inhibitor in Patients with Recurrent Glioblastoma

BERLIN , Feb. 29, 2024 /PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, is pleased to announce that it has ...


Cancer Hope Network Announces One-On-One Peer Mentorship Collaboration with Lazarex Cancer Foundation

New collaboration helps address barriers to clinical trials participation, expands resources to patients and caregivers CHESTER, N.J. , Feb. 28, 2024 /PRNewswire-PRWeb/ -- Cancer Hope Network and Lazarex Cancer Foundation announced ...

HPV's Hidden Hand: New Study by Pusan National University Scientists Reveals Key Details in Head and Neck Cancer Microenvironment

Using RNA sequencing and spatial transcriptomics, the roles of PKM gene and EPHA2 pathway in the development of HNSCC were discovered. BUSAN, South Korea , Feb. 28, 2024 /PRNewswire/ -- Head and neck squamous cell carcinoma (HNSCC) is ...

The promising results of a phase II clinical study for Akeso's Cadonilimab (PD-1/CTLA-4) combined standard treatment for first-line treatment of R/M cervical cancer has been published in Clinical Cancer Research

HONG KONG , Feb. 28, 2024 /PRNewswire/ -- Akeso (9926.HK) announced that the results of a phase II clinical trial for PD-1/CTLA-4 bispecific antibody(cadonilimab)combined with standard treatment (chemotherapy +/- bevacizumab) as ...

British Technology company, C the Signs, selected by the White House-Backed Accelerator Programme, CancerX, to half Cancer Deaths

LONDON , Feb. 27, 2024 /PRNewswire/ -- C the Signs , a British AI technology company founded by NHS Doctors at the forefront of early cancer detection, has been announced as part of the inaugural cohort of the White House CancerX ...

Cure Brain Cancer Foundation CEO Lance Kawaguchi Completes SouthPoleTrek4Cancer, Raises Over $1 Million for Cancer Research

SYDNEY , Feb. 26, 2024 /PRNewswire/ -- In an unprecedented feat of endurance and dedication to cancer research, Lance Kawaguchi , Chief Executive Officer of Cure Brain Cancer Foundation, successfully completed a challenging trek at the ...

DiaCarta, Inc. and OncoAssure Ltd. Collaborate to Launch Prostate Cancer Lab Developed Test

PLEASANTON, Calif. , Feb. 26, 2024 /PRNewswire/ -- DiaCarta, Inc. ("DiaCarta"), a pioneer in molecular diagnostic test development for cancer and infectious diseases, today announced that it has established a strategic collaboration with ...

Immunofoco Announces the Dual Approval of IND Applications by the U.S. FDA and China CDE for the First EpCAM CAR-T Targeted at Advanced Solid Tumors

- The first EpCAM targeted CAR-T product obtained US/CN IND approval. -   Acceptable safety profiles and preliminary efficacy were observed in Investigator-Initiated Trial   ( IIT ) clinical studies of IMC001. SHANGHAI , Feb. ...

STORM Therapeutics to Present Findings on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at ESMO Targeted Anticancer Therapies Congress

Data demonstrates pharmacological inhibition of METTL1 inhibits tumour growth  and reduces tRNA methylation and stability of tRNAs CAMBRIDGE, England , Feb. 22, 2024 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the clinical ...

Kling Biotherapeutics to Present Discoveries on its Primary B-Cell Screening Platform at the ESMO Targeted Anticancer Therapies Congress

Kling reports on advancing pipeline of therapeutic antibodies targeting novel antigens discovered with its best-in-class B-cell screening platform, Kling-Select Progress on in vitro and in vivo validation of two highly specific tumor ...

Cancer News »

Unraveling Genetic Variant's Role in Childhood Leukemia Risk

Unraveling Genetic Variant's Role in Childhood Leukemia Risk

A recent study conducted by the Keck School of Medicine of USC has uncovered a significant genetic variant located on the IKZF1 gene, shedding light on the heightened risk of Acute Lymphoblastic Leukemia (ALL) ( ). Through genetic fine-mapping ...

Why Colon Cancer Strikes Younger Indians?

Why Colon Cancer Strikes Younger Indians?

In India, there is a notable increase in colon or colorectal cancer cases among young adults. This surge is attributed to delayed diagnoses, inadequate screening, and the adoption of a Western diet characterized by highly processed and calorie-rich ...

Bacterial Subtype Linked to Growth in 50% of Colorectal Cancers

Bacterial Subtype Linked to Growth in 50% of Colorectal Cancers

Scientists at Fred Hutchinson Cancer Research Center have discovered that a particular subtype of microbe Fusobacterium nucleatum, often present in oral microbiota, can migrate to the gut and thrive within colorectal cancer tumors. This microbe has ...

Dr. Reddy's Introduces New Cancer Treatment to the UK Market

Dr. Reddy's Introduces New Cancer Treatment to the UK Market

Pharmaceutical giant Dr. Reddy’s Laboratories Ltd (DRL) unveiled the release of its cancer medication Versavo (bevacizumab) in the United Kingdom ( ). Dr. Reddy’s Launches Versavo, First Biosimilar in UK for Treating Various Cancers ...

HPV Vaccine: Cervical Cancer Prevention Beyond Age 26

HPV Vaccine: Cervical Cancer Prevention Beyond Age 26

Although the recommended age for receiving the HPV vaccine is between 9 and 14, women who missed the vaccination during this period can still gain partial protection against...

More Cancer News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.